Iopromide
This non-ionic, low-osmolality iodinated contrast agent is used for CT scans, angiography, urography, and other diagnostic imaging procedures. It reduces X-ray transparency in the tissues and blood vessels it passes through, improving the visibility of structures. Its low osmolality profile is associated with good tolerability and lower risk of adverse reactions.
Berat Molekul
791,1000 g/mol
LogP
-2,10
TPSA
169,00 Ų
Lipinski RO5
Gagal
Area Terapeutik
Mekanisme Kerja
Functions as a diagnostic agent by providing contrast enhancement or radioactive tracer activity that enables visualization of anatomical structures or physiological processes during medical imaging.
Pharmacokinetics (PK)
Pharmacodynamics (PD)
Functions as a diagnostic agent by providing contrast enhancement or radioactive tracer activity that enables visualization of anatomical structures or physiological processes during medical imaging.
Struktur 2D
Cite this structure
Embed this structure
SMILES
COCC(=O)Nc1c(I)c(C(=O)NCC(O)CO)c(I)c(C(=O)N(C)CC(O)CO)c1I
InChI
InChI=1S/C18H24I3N3O8/c1-24(4-9(28)6-26)18(31)12-13(19)11(17(30)22-3-8(27)5-25)14(20)16(15(12)21)23-10(29)7-32-2/h8-9,25-28H,3-7H2,1-2H3,(H,22,30)(H,23,29)
Molecular Formula
C18H24I3N3O8
HBD / HBA
6 / 8
Ikatan yang Dapat Dirotasi
11
Atom Berat
32
No targets recorded
Target interaction data is not yet available for this drug.
No interactions recorded
Drug interaction data is not yet available for this compound.
No side effects recorded
Side effect data is not yet available for this drug.
Pertanyaan yang Sering Diajukan
This non-ionic, low-osmolality iodinated contrast agent is used for CT scans, angiography, urography, and other diagnostic imaging procedures. It reduces X-ray transparency in the tissues and blood vessels it passes through, improving the visibility of structures. Its low osmolality profile is associated with good tolerability and lower risk of adverse reactions.
Functions as a diagnostic agent by providing contrast enhancement or radioactive tracer activity that enables visualization of anatomical structures or physiological processes during medical imaging.
Yes, Iopromide is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.
References & Data Sources
- ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1725. Open-access bioactivity database.
- PubChem — National Center for Biotechnology Information (NCBI). CID 3736. Chemical information database.
Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.
Embed This Widget
Add the script tag and a data attribute to embed this widget.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<div data-drugfyi="drug" data-slug="iopromide"></div>Embed via iframe for maximum compatibility.
<iframe src="https://drugfyi.com/iframe/drug/iopromide/" width="420" height="400" frameborder="0" style="border:0;border-radius:10px;max-width:100%" loading="lazy"></iframe>Paste this URL in WordPress, Medium, or any oEmbed-compatible platform.
https://drugfyi.com/drug/iopromide/Add a dynamic SVG badge to your README or docs.
[](https://drugfyi.com/drug/iopromide/)Use the native HTML custom element.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<drugfyi-drug slug="iopromide"></drugfyi-drug>